APO Research
Talk to an analyst

APO RESEARCH · REPORT

Direct Agglutination Test

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Direct Agglutination Test Market Analysis and Forecast 2026-2032

5 July 2026172 pages

Choose your research edition.

Industry ResearchDirect Agglutination Test Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Direct Agglutination Test Industry Growth and Trends Forecast to 203289 pages · $3,450 USDMarket StructureGlobal Direct Agglutination Test Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032185 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Direct Agglutination Test Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Direct Agglutination Test Market Analysis and Forecast 2026-2032172 pages · $4,950 USD

Market perspective

The global Direct Agglutination Test market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Direct Agglutination Test is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Direct Agglutination Test is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Direct Agglutination Test is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Direct Agglutination Test is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Direct Agglutination Test include Atlas Medical GmbH, Thermo Fisher Scientific, Bio-Rad, HiMedia, Pro Lab, Arlington Scientific, Hardy Diagnostics, Liofilchem S.r.l and Biotec, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Direct Agglutination Test, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Direct Agglutination Test, also provides the revenue of main regions and countries. Of the upcoming market potential for Direct Agglutination Test, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Direct Agglutination Test revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Direct Agglutination Test market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Direct Agglutination Test revenue, projected growth trends, production technology, application and end-user industry.

Direct Agglutination Test Segment by Company

Atlas Medical GmbH

Thermo Fisher Scientific

Bio-Rad

HiMedia

Pro Lab

Arlington Scientific

Hardy Diagnostics

Liofilchem S.r.l

Biotec

Direct Agglutination Test Segment by Type

Blood

Urine

Escherichia Coli

Others

Direct Agglutination Test Segment by Application

Clinics

Hospital

Other

Direct Agglutination Test Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Direct Agglutination Test market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Direct Agglutination Test and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Direct Agglutination Test.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Direct Agglutination Test in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Direct Agglutination Test company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Direct Agglutination Test revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Direct Agglutination Test Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Blood Major Player Table 3. Urine Major Player Table 4. Escherichia Coli Major Player Table 5. Others Major Player Table 6. Global Direct Agglutination Test Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Clinics Major Player Table 8. Hospital Major Player Table 9. Other Major Player Table 10. Direct Agglutination Test Industry Trends Table 11. Direct Agglutination Test Industry Drivers Table 12. Direct Agglutination Test Industry Opportunities and Challenges Table 13. Direct Agglutination Test Industry Restraints Table 14. Global Direct Agglutination Test Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 15. Global Direct Agglutination Test Market Size by Region (2021-2026) & (US$ Million) Table 16. Global Direct Agglutination Test Market Share by Region (2021-2026) Table 17. Global Direct Agglutination Test Market Size by Region (2027-2032) & (US$ Million) Table 18. Global Direct Agglutination Test Market Share by Region (2027-2032) Table 19. Global Direct Agglutination Test Revenue by Players (US$ Million) & (2021-2026) Table 20. Global Direct Agglutination Test Revenue Market Share by Players (2021-2026) Table 21. Global Direct Agglutination Test Key Players Ranking, 2024 VS 2025 VS 2026 Table 22. Global Direct Agglutination Test Key Players Headquarters & Area Served Table 23. Global Direct Agglutination Test Players, Product Type & Application Table 24. Global Direct Agglutination Test Players Establishment Date Table 25. Global Players Market Concentration Ratio (CR5 and HHI) Table 26. Global Direct Agglutination Test by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 27. Global Direct Agglutination Test Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Direct Agglutination Test Revenue by Type (2021-2026) & (US$ Million) Table 29. Global Direct Agglutination Test Revenue by Type (2027-2032) & (US$ Million) Table 30. Global Direct Agglutination Test Revenue Market Share by Type (2021-2026) Table 31. Global Direct Agglutination Test Revenue Market Share by Type (2027-2032) Table 32. Global Direct Agglutination Test Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Direct Agglutination Test Revenue by Application (2021-2026) & (US$ Million) Table 34. Global Direct Agglutination Test Revenue by Application (2027-2032) & (US$ Million) Table 35. Global Direct Agglutination Test Revenue Market Share by Application (2021-2026) Table 36. Global Direct Agglutination Test Revenue Market Share by Application (2027-2032) Table 37. Atlas Medical GmbH Company Information Table 38. Atlas Medical GmbH Business Overview Table 39. Atlas Medical GmbH Direct Agglutination Test Revenue and Gross Margin (US$ Million) & (2021-2026) Table 40. Atlas Medical GmbH Direct Agglutination Test Product Portfolio Table 41. Atlas Medical GmbH Recent Development Table 42. Thermo Fisher Scientific Company Information Table 43. Thermo Fisher Scientific Business Overview Table 44. Thermo Fisher Scientific Direct Agglutination Test Revenue and Gross Margin (US$ Million) & (2021-2026) Table 45. Thermo Fisher Scientific Direct Agglutination Test Product Portfolio Table 46. Thermo Fisher Scientific Recent Development Table 47. Bio-Rad Company Information Table 48. Bio-Rad Business Overview Table 49. Bio-Rad Direct Agglutination Test Revenue and Gross Margin (US$ Million) & (2021-2026) Table 50. Bio-Rad Direct Agglutination Test Product Portfolio Table 51. Bio-Rad Recent Development Table 52. HiMedia Company Information Table 53. HiMedia Business Overview Table 54. HiMedia Direct Agglutination Test Revenue and Gross Margin (US$ Million) & (2021-2026) Table 55. HiMedia Direct Agglutination Test Product Portfolio Table 56. HiMedia Recent Development Table 57. Pro Lab Company Information Table 58. Pro Lab Business Overview Table 59. Pro Lab Direct Agglutination Test Revenue and Gross Margin (US$ Million) & (2021-2026) Table 60. Pro Lab Direct Agglutination Test Product Portfolio Table 61. Pro Lab Recent Development Table 62. Arlington Scientific Company Information Table 63. Arlington Scientific Business Overview Table 64. Arlington Scientific Direct Agglutination Test Revenue and Gross Margin (US$ Million) & (2021-2026) Table 65. Arlington Scientific Direct Agglutination Test Product Portfolio Table 66. Arlington Scientific Recent Development Table 67. Hardy Diagnostics Company Information Table 68. Hardy Diagnostics Business Overview Table 69. Hardy Diagnostics Direct Agglutination Test Revenue and Gross Margin (US$ Million) & (2021-2026) Table 70. Hardy Diagnostics Direct Agglutination Test Product Portfolio Table 71. Hardy Diagnostics Recent Development Table 72. Liofilchem S.r.l Company Information Table 73. Liofilchem S.r.l Business Overview Table 74. Liofilchem S.r.l Direct Agglutination Test Revenue and Gross Margin (US$ Million) & (2021-2026) Table 75. Liofilchem S.r.l Direct Agglutination Test Product Portfolio Table 76. Liofilchem S.r.l Recent Development Table 77. Biotec Company Information Table 78. Biotec Business Overview Table 79. Biotec Direct Agglutination Test Revenue and Gross Margin (US$ Million) & (2021-2026) Table 80. Biotec Direct Agglutination Test Product Portfolio Table 81. Biotec Recent Development Table 82. North America Direct Agglutination Test Revenue by Type (2021-2026) & (US$ Million) Table 83. North America Direct Agglutination Test Revenue by Type (2027-2032) & (US$ Million) Table 84. North America Direct Agglutination Test Revenue by Application (2021-2026) & (US$ Million) Table 85. North America Direct Agglutination Test Revenue by Application (2027-2032) & (US$ Million) Table 86. North America Direct Agglutination Test Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 87. North America Direct Agglutination Test Revenue by Country (2021-2026) & (US$ Million) Table 88. North America Direct Agglutination Test Revenue by Country (US$ Million) & (2027-2032) Table 89. Europe Direct Agglutination Test Revenue by Type (2021-2026) & (US$ Million) Table 90. Europe Direct Agglutination Test Revenue by Type (2027-2032) & (US$ Million) Table 91. Europe Direct Agglutination Test Revenue by Application (2021-2026) & (US$ Million) Table 92. Europe Direct Agglutination Test Revenue by Application (2027-2032) & (US$ Million) Table 93. Europe Direct Agglutination Test Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 94. Europe Direct Agglutination Test Revenue by Country (2021-2026) & (US$ Million) Table 95. Europe Direct Agglutination Test Revenue by Country (US$ Million) & (2027-2032) Table 96. China Direct Agglutination Test Revenue by Type (2021-2026) & (US$ Million) Table 97. China Direct Agglutination Test Revenue by Type (2027-2032) & (US$ Million) Table 98. China Direct Agglutination Test Revenue by Application (2021-2026) & (US$ Million) Table 99. China Direct Agglutination Test Revenue by Application (2027-2032) & (US$ Million) Table 100. Asia Direct Agglutination Test Revenue by Type (2021-2026) & (US$ Million) Table 101. Asia Direct Agglutination Test Revenue by Type (2027-2032) & (US$ Million) Table 102. Asia Direct Agglutination Test Revenue by Application (2021-2026) & (US$ Million) Table 103. Asia Direct Agglutination Test Revenue by Application (2027-2032) & (US$ Million) Table 104. Asia Direct Agglutination Test Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 105. Asia Direct Agglutination Test Revenue by Region (US$ Million) & (2021-2026) Table 106. Asia Direct Agglutination Test Revenue by Region (US$ Million) & (2027-2032) Table 107. SAMEA Direct Agglutination Test Revenue by Type (2021-2026) & (US$ Million) Table 108. SAMEA Direct Agglutination Test Revenue by Type (2027-2032) & (US$ Million) Table 109. SAMEA Direct Agglutination Test Revenue by Application (2021-2026) & (US$ Million) Table 110. SAMEA Direct Agglutination Test Revenue by Application (2027-2032) & (US$ Million) Table 111. SAMEA Direct Agglutination Test Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 112. SAMEA Direct Agglutination Test Revenue by Country (2021-2026) & (US$ Million) Table 113. SAMEA Direct Agglutination Test Revenue by Country (US$ Million) & (2027-2032) Table 114. Research Programs/Design for This Report Table 115. Authors List of This Report Table 116. Secondary Sources Table 117. Primary Sources List of Figures Figure 1. Direct Agglutination Test Image Figure 2. Global Direct Agglutination Test Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Direct Agglutination Test Market Size Share 2021 VS 2025 VS 2032 Figure 4. Blood Image Figure 5. Urine Image Figure 6. Escherichia Coli Image Figure 7. Others Image Figure 8. Global Direct Agglutination Test Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global Direct Agglutination Test Market Size Share 2021 VS 2025 VS 2032 Figure 10. Clinics Image Figure 11. Hospital Image Figure 12. Other Image Figure 13. Global Direct Agglutination Test Market Size (US$ Million) & (2021-2032) Figure 14. Global Direct Agglutination Test Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global Direct Agglutination Test Market Share by Region: 2021 VS 2025 VS 2032 Figure 16. Global Direct Agglutination Test Players Revenue Share Top 10 and Top 5 in 2025 Figure 17. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global Direct Agglutination Test Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Direct Agglutination Test Revenue Market Share 2021 VS 2025 VS 2032 Figure 20. Global Direct Agglutination Test Revenue Market Share by Type (2021-2032) Figure 21. Global Direct Agglutination Test Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Direct Agglutination Test Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 23. Global Direct Agglutination Test Revenue Market Share by Application (2021-2032) Figure 24. North America Direct Agglutination Test Revenue YoY Growth (2021-2032) & (US$ Million) Figure 25. North America Direct Agglutination Test Revenue Share by Type (2021-2032) Figure 26. North America Direct Agglutination Test Revenue Share by Application (2021-2032) Figure 27. North America Direct Agglutination Test Revenue Share by Country (2021-2032) Figure 28. United States Direct Agglutination Test Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Canada Direct Agglutination Test Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Mexico Direct Agglutination Test Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Europe Direct Agglutination Test Revenue YoY Growth (2021-2032) & (US$ Million) Figure 32. Europe Direct Agglutination Test Revenue Share by Type (2021-2032) Figure 33. Europe Direct Agglutination Test Revenue Share by Application (2021-2032) Figure 34. Europe Direct Agglutination Test Revenue Share by Country (2021-2032) Figure 35. Germany Direct Agglutination Test Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. France Direct Agglutination Test Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. U.K. Direct Agglutination Test Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Italy Direct Agglutination Test Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Spain Direct Agglutination Test Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Russia Direct Agglutination Test Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Netherlands Direct Agglutination Test Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Nordic Countries Direct Agglutination Test Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. China Direct Agglutination Test Revenue YoY Growth (2021-2032) & (US$ Million) Figure 44. China Direct Agglutination Test Revenue Share by Type (2021-2032) Figure 45. China Direct Agglutination Test Revenue Share by Application (2021-2032) Figure 46. Asia Direct Agglutination Test Revenue YoY Growth (2021-2032) & (US$ Million) Figure 47. Asia Direct Agglutination Test Revenue Share by Type (2021-2032) Figure 48. Asia Direct Agglutination Test Revenue Share by Application (2021-2032) Figure 49. Asia Direct Agglutination Test Revenue Share by Region (2021-2032) Figure 50. Japan Direct Agglutination Test Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. South Korea Direct Agglutination Test Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. India Direct Agglutination Test Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Australia Direct Agglutination Test Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Taiwan Direct Agglutination Test Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Southeast Asia Direct Agglutination Test Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. SAMEA Direct Agglutination Test Revenue YoY Growth (2021-2032) & (US$ Million) Figure 57. SAMEA Direct Agglutination Test Revenue Share by Type (2021-2032) Figure 58. SAMEA Direct Agglutination Test Revenue Share by Application (2021-2032) Figure 59. SAMEA Direct Agglutination Test Revenue Share by Country (2021-2032) Figure 60. Brazil Direct Agglutination Test Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Argentina Direct Agglutination Test Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Chile Direct Agglutination Test Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Colombia Direct Agglutination Test Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Peru Direct Agglutination Test Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Saudi Arabia Direct Agglutination Test Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Israel Direct Agglutination Test Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. UAE Direct Agglutination Test Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Turkey Direct Agglutination Test Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Iran Direct Agglutination Test Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Egypt Direct Agglutination Test Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Blood
  • Urine
  • Escherichia Coli
  • Others
Applications
  • Clinics
  • Hospital
  • Other
Companies covered
  • Atlas Medical GmbH
  • Thermo Fisher Scientific
  • Bio-Rad
  • HiMedia
  • Pro Lab
  • Arlington Scientific
  • Hardy Diagnostics
  • Liofilchem S.r.l
  • Biotec

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Direct Agglutination Test Market by Type
  3. 1.2.1 Global Direct Agglutination Test Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Blood
  5. 1.2.3 Urine
  6. 1.2.4 Escherichia Coli
  7. 1.2.5 Others
  8. 1.3 Direct Agglutination Test Market by Application
  9. 1.3.1 Global Direct Agglutination Test Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Clinics
  11. 1.3.3 Hospital
  12. 1.3.4 Other
  13. 1.4 Assumptions and Limitations
  14. 1.5 Study Goals and Objectives
2 Direct Agglutination Test Market Dynamics
  1. 2.1 Direct Agglutination Test Industry Trends
  2. 2.2 Direct Agglutination Test Industry Drivers
  3. 2.3 Direct Agglutination Test Industry Opportunities and Challenges
  4. 2.4 Direct Agglutination Test Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Direct Agglutination Test Market Perspective (2021-2032)
  2. 3.2 Global Direct Agglutination Test Growth Trends by Region
  3. 3.2.1 Global Direct Agglutination Test Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Direct Agglutination Test Market Size by Region (2021-2026)
  5. 3.2.3 Global Direct Agglutination Test Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Direct Agglutination Test Revenue by Players
  2. 4.1.1 Global Direct Agglutination Test Revenue by Players (2021-2026)
  3. 4.1.2 Global Direct Agglutination Test Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Direct Agglutination Test Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Direct Agglutination Test Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Direct Agglutination Test Key Players Headquarters & Area Served
  7. 4.4 Global Direct Agglutination Test Players, Product Type & Application
  8. 4.5 Global Direct Agglutination Test Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Direct Agglutination Test Market CR5 and HHI
  11. 4.6.3 2025 Direct Agglutination Test Tier 1, Tier 2, and Tier 3
5 Direct Agglutination Test Market Size by Type
  1. 5.1 Global Direct Agglutination Test Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Direct Agglutination Test Revenue by Type (2021-2032)
  3. 5.3 Global Direct Agglutination Test Revenue Market Share by Type (2021-2032)
6 Direct Agglutination Test Market Size by Application
  1. 6.1 Global Direct Agglutination Test Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Direct Agglutination Test Revenue by Application (2021-2032)
  3. 6.3 Global Direct Agglutination Test Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Atlas Medical GmbH
  2. 7.1.1 Atlas Medical GmbH Company Information
  3. 7.1.2 Atlas Medical GmbH Business Overview
  4. 7.1.3 Atlas Medical GmbH Direct Agglutination Test Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Atlas Medical GmbH Direct Agglutination Test Product Portfolio
  6. 7.1.5 Atlas Medical GmbH Recent Developments
  7. 7.2 Thermo Fisher Scientific
  8. 7.2.1 Thermo Fisher Scientific Company Information
  9. 7.2.2 Thermo Fisher Scientific Business Overview
  10. 7.2.3 Thermo Fisher Scientific Direct Agglutination Test Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Thermo Fisher Scientific Direct Agglutination Test Product Portfolio
  12. 7.2.5 Thermo Fisher Scientific Recent Developments
  13. 7.3 Bio-Rad
  14. 7.3.1 Bio-Rad Company Information
  15. 7.3.2 Bio-Rad Business Overview
  16. 7.3.3 Bio-Rad Direct Agglutination Test Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Bio-Rad Direct Agglutination Test Product Portfolio
  18. 7.3.5 Bio-Rad Recent Developments
  19. 7.4 HiMedia
  20. 7.4.1 HiMedia Company Information
  21. 7.4.2 HiMedia Business Overview
  22. 7.4.3 HiMedia Direct Agglutination Test Revenue and Gross Margin (2021-2026)
  23. 7.4.4 HiMedia Direct Agglutination Test Product Portfolio
  24. 7.4.5 HiMedia Recent Developments
  25. 7.5 Pro Lab
  26. 7.5.1 Pro Lab Company Information
  27. 7.5.2 Pro Lab Business Overview
  28. 7.5.3 Pro Lab Direct Agglutination Test Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Pro Lab Direct Agglutination Test Product Portfolio
  30. 7.5.5 Pro Lab Recent Developments
  31. 7.6 Arlington Scientific
  32. 7.6.1 Arlington Scientific Company Information
  33. 7.6.2 Arlington Scientific Business Overview
  34. 7.6.3 Arlington Scientific Direct Agglutination Test Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Arlington Scientific Direct Agglutination Test Product Portfolio
  36. 7.6.5 Arlington Scientific Recent Developments
  37. 7.7 Hardy Diagnostics
  38. 7.7.1 Hardy Diagnostics Company Information
  39. 7.7.2 Hardy Diagnostics Business Overview
  40. 7.7.3 Hardy Diagnostics Direct Agglutination Test Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Hardy Diagnostics Direct Agglutination Test Product Portfolio
  42. 7.7.5 Hardy Diagnostics Recent Developments
  43. 7.8 Liofilchem S.r.l
  44. 7.8.1 Liofilchem S.r.l Company Information
  45. 7.8.2 Liofilchem S.r.l Business Overview
  46. 7.8.3 Liofilchem S.r.l Direct Agglutination Test Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Liofilchem S.r.l Direct Agglutination Test Product Portfolio
  48. 7.8.5 Liofilchem S.r.l Recent Developments
  49. 7.9 Biotec
  50. 7.9.1 Biotec Company Information
  51. 7.9.2 Biotec Business Overview
  52. 7.9.3 Biotec Direct Agglutination Test Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Biotec Direct Agglutination Test Product Portfolio
  54. 7.9.5 Biotec Recent Developments
8 North America
  1. 8.1 North America Direct Agglutination Test Revenue (2021-2032)
  2. 8.2 North America Direct Agglutination Test Revenue by Type (2021-2032)
  3. 8.2.1 North America Direct Agglutination Test Revenue by Type (2021-2026)
  4. 8.2.2 North America Direct Agglutination Test Revenue by Type (2027-2032)
  5. 8.3 North America Direct Agglutination Test Revenue Share by Type (2021-2032)
  6. 8.4 North America Direct Agglutination Test Revenue by Application (2021-2032)
  7. 8.4.1 North America Direct Agglutination Test Revenue by Application (2021-2026)
  8. 8.4.2 North America Direct Agglutination Test Revenue by Application (2027-2032)
  9. 8.5 North America Direct Agglutination Test Revenue Share by Application (2021-2032)
  10. 8.6 North America Direct Agglutination Test Revenue by Country
  11. 8.6.1 North America Direct Agglutination Test Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Direct Agglutination Test Revenue by Country (2021-2026)
  13. 8.6.3 North America Direct Agglutination Test Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Direct Agglutination Test Revenue (2021-2032)
  2. 9.2 Europe Direct Agglutination Test Revenue by Type (2021-2032)
  3. 9.2.1 Europe Direct Agglutination Test Revenue by Type (2021-2026)
  4. 9.2.2 Europe Direct Agglutination Test Revenue by Type (2027-2032)
  5. 9.3 Europe Direct Agglutination Test Revenue Share by Type (2021-2032)
  6. 9.4 Europe Direct Agglutination Test Revenue by Application (2021-2032)
  7. 9.4.1 Europe Direct Agglutination Test Revenue by Application (2021-2026)
  8. 9.4.2 Europe Direct Agglutination Test Revenue by Application (2027-2032)
  9. 9.5 Europe Direct Agglutination Test Revenue Share by Application (2021-2032)
  10. 9.6 Europe Direct Agglutination Test Revenue by Country
  11. 9.6.1 Europe Direct Agglutination Test Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Direct Agglutination Test Revenue by Country (2021-2026)
  13. 9.6.3 Europe Direct Agglutination Test Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Direct Agglutination Test Revenue (2021-2032)
  2. 10.2 China Direct Agglutination Test Revenue by Type (2021-2032)
  3. 10.2.1 China Direct Agglutination Test Revenue by Type (2021-2026)
  4. 10.2.2 China Direct Agglutination Test Revenue by Type (2027-2032)
  5. 10.3 China Direct Agglutination Test Revenue Share by Type (2021-2032)
  6. 10.4 China Direct Agglutination Test Revenue by Application (2021-2032)
  7. 10.4.1 China Direct Agglutination Test Revenue by Application (2021-2026)
  8. 10.4.2 China Direct Agglutination Test Revenue by Application (2027-2032)
  9. 10.5 China Direct Agglutination Test Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Direct Agglutination Test Revenue (2021-2032)
  2. 11.2 Asia Direct Agglutination Test Revenue by Type (2021-2032)
  3. 11.2.1 Asia Direct Agglutination Test Revenue by Type (2021-2026)
  4. 11.2.2 Asia Direct Agglutination Test Revenue by Type (2027-2032)
  5. 11.3 Asia Direct Agglutination Test Revenue Share by Type (2021-2032)
  6. 11.4 Asia Direct Agglutination Test Revenue by Application (2021-2032)
  7. 11.4.1 Asia Direct Agglutination Test Revenue by Application (2021-2026)
  8. 11.4.2 Asia Direct Agglutination Test Revenue by Application (2027-2032)
  9. 11.5 Asia Direct Agglutination Test Revenue Share by Application (2021-2032)
  10. 11.6 Asia Direct Agglutination Test Revenue by Country
  11. 11.6.1 Asia Direct Agglutination Test Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Direct Agglutination Test Revenue by Country (2021-2026)
  13. 11.6.3 Asia Direct Agglutination Test Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Direct Agglutination Test Revenue (2021-2032)
  2. 12.2 SAMEA Direct Agglutination Test Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Direct Agglutination Test Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Direct Agglutination Test Revenue by Type (2027-2032)
  5. 12.3 SAMEA Direct Agglutination Test Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Direct Agglutination Test Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Direct Agglutination Test Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Direct Agglutination Test Revenue by Application (2027-2032)
  9. 12.5 SAMEA Direct Agglutination Test Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Direct Agglutination Test Revenue by Country
  11. 12.6.1 SAMEA Direct Agglutination Test Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Direct Agglutination Test Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Direct Agglutination Test Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst